Timothy Heffernan, Ph.D., is vice president and head of oncology research in the therapeutics discovery division, a Biotech-like organization, at The University of Texas MD Anderson Cancer Center in Houston. In this role, Dr. Heffernan manages the development of an advanced drug discovery and development portfolio, coordinating research on programs from target identification through clinical development. During his time at MD Anderson, Dr. Heffernan has advanced 12 internal or partnered therapeutics into clinical trials.
Prior to joining MD Anderson, Dr. Heffernan served as senior vice president at C4 Therapeutics Inc., overseeing drug discovery and translational biology efforts to advance a portfolio of internal and partnered programs.
Dr. Heffernan earned a doctor of philosophy degree in cell and molecular pathology from the University of North Carolina at Chapel Hill and completed his postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School in Boston.